Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation (vol 159, 104944, 2020)

被引：0

作者：

Chen, Delong ^{[1
,2
]}

Ye, Zhen ^{[3
]}

Wang, Chao ^{[2
]}

Wang, Qingqing ^{[2
,4
]}

Wang, Haibin ^{[5
]}

Kuek, Vincent ^{[2
]}

Wang, Ziyi ^{[2
]}

Qiu, Heng ^{[2
]}

Yuan, Jinbo ^{[2
]}

Kenny, Jacob ^{[2
]}

Yang, Fan ^{[6
,7
]}

He, Jianbo ^{[2
,8
]}

Liu, Yun ^{[2
,9
]}

Wang, Gang ^{[2
,8
]}

Zhang, Meng ^{[8
]}

Zhang, Gangyu ^{[8
]}

Wang, Junjian ^{[10
]}

Chen, Peng ^{[5
]}

Xu, Jiake ^{[2
]}

机构：

[1] Jinan Univ, Clifford Hosp, Dept Orthopaed Surg, Guangzhou 510006, Peoples R China

[2] Univ Western Australia, Sch Biomed Sci, Perth, WA 6009, Australia

[3] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou 325000, Peoples R China

[4] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Orthopaed Surg, Hangzhou 310000, Peoples R China

[5] Guangzhou Univ Chinese Med, Dept Orthopaed Surg, Affiliated Hosp 1, Guangzhou 510405, Peoples R China

[6] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, MOE Key Lab Standardizat Chinese Med, Shanghai 201203, Peoples R China

[7] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, SHTCM Key Lab New Resources & Qual Evaluat Chinese, Shanghai 201203, Peoples R China

[8] Guangzhou Univ Chinese Med, Guangzhou 510405, Peoples R China

[9] Guangxi Med Univ, Affiliated Hosp 1, Dept Spine Osteopathy Surg, Nanning 530021, Peoples R China

[10] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510006, Peoples R China

来源：

PHARMACOLOGICAL RESEARCH | 2024年 / 209卷

关键词：

D O I：

10.1016/j.phrs.2024.107463

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页数：3

共 50 条

[1] Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation
Chen, Delong
Ye, Zhen
Wang, Chao
Wang, Qingqing
Wang, Haibin
Kuek, Vincent
Wang, Ziyi
Qiu, Heng
Yuan, Jinbo
Kenny, Jacob
Yang, Fan
He, Jianbo
Liu, Yun
Wang, Gang
Zhang, Meng
Zhang, Gangyu
Wang, Junjian
Chen, Peng
Xu, Jiake
PHARMACOLOGICAL RESEARCH, 2020, 159
[2] Oroxylin A reduces osteoclast formation and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation
Xian, Yansi
Su, Yuangang
Liang, Jiamin
Long, Feng
Feng, Xiaoliang
Xiao, Yu
Lian, Haoyu
Xu, Jiake
Zhao, Jinmin
Liu, Qian
Song, Fangming
BIOCHEMICAL PHARMACOLOGY, 2021, 193
[3] Cytochalasin Z11 inhibits RANKL-induced osteoclastogenesis via suppressing NFATc1 activation
Wang, Lu
Chen, Kai
He, Jianbo
Kenny, Jacob
Yuan, Yu
Chen, Junhao
Liu, Qian
Tan, Renxiang
Zhao, Jinmin
Xu, Jiake
RSC ADVANCES, 2019, 9 (66) : 38438 - 38446
[4] Hispidulin attenuates bone resorption and osteoclastogenesis via the RANKL-induced NF-κB and NFATc1 pathways
Nepal, Manoj
Choi, Hwa Jung
Choi, Bo-Yun
Yang, Moon-Shik
Chae, Jung-Il
Li, Liang
Soh, Yunjo
EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 715 (1-3) : 96 - 104
[5] C-phycocyanin attenuates RANKL-induced osteoclastogenesis and bone resorption in vitro through inhibiting ROS levels, NFATc1 and NF-κB activation
Mohammed S. AlQranei
Hanan Aljohani
Sunipa Majumdar
Linda T. Senbanjo
Meenakshi A. Chellaiah
Scientific Reports, 10
[6] Adseverin mediates RANKL-induced osteoclastogenesis by regulating NFATc1
Min-Kyoung Song
Zang Hee Lee
Hong-Hee Kim
Experimental & Molecular Medicine, 2015, 47 : e199 - e199
[7] C-phycocyanin attenuates RANKL-induced osteoclastogenesis and bone resorption in vitro through inhibiting ROS levels, NFATc1 and NF-κB activation
AlQranei, Mohammed S.
Aljohani, Hanan
Majumdar, Sunipa
Senbanjo, Linda T.
Chellaiah, Meenakshi A.
SCIENTIFIC REPORTS, 2020, 10 (01)
[8] Adseverin mediates RANKL-induced osteoclastogenesis by regulating NFATc1
Song, Min-Kyoung
Lee, Zang Hee
Kim, Hong-Hee
EXPERIMENTAL AND MOLECULAR MEDICINE, 2015, 47 : e199 - e199
[9] Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis via attenuating NFATc1 and ROS activities
Liu, Yuhao
Wang, Chao
Wang, Gang
Sun, Youqiang
Deng, Zhangrong
Chen, Leilei
Chen, Kai
Tickner, Jennifer
Kenny, Jacob
Song, Dezhi
Zhang, Qingwen
Wang, Haibin
Chen, Zhenqiu
Zhou, Chi
He, Wei
Xu, Jiake
THERANOSTICS, 2019, 9 (16): : 4648 - 4662
[10] Corylifol A protects against ovariectomized-induced bone loss and attenuates RANKL-induced osteoclastogenesis via ROS reduction, ERK inhibition, and NFATc1 activation
Xu, Yinglong
Song, Dezhi
Lin, Xixi
Peng, Hui
Su, Yuangang
Liang, Jiamin
Hai, Na
Zhao, Jinmin
Liu, Qian
FREE RADICAL BIOLOGY AND MEDICINE, 2023, 196 : 121 - 132

← 1 2 3 4 5 →